Vitamin C for preventing and treating the common cold

Area of Science:

• Nutritional Science
• Public Health
• Preventive Medicine

Background:

• The efficacy of vitamin C (ascorbic acid) for common cold prevention and treatment remains debated despite its widespread use.
• Sixty years of research have yielded controversial results regarding vitamin C's role in managing colds.

Purpose of the Study:

• To determine if daily oral vitamin C (≥0.2g) impacts the incidence, duration, or severity of the common cold.
• To evaluate vitamin C's effectiveness as both a continuous prophylactic measure and a post-symptom therapeutic intervention.

Main Methods:

• Systematic review and meta-analysis of controlled trials.
• Searched Cochrane CENTRAL, MEDLINE, and EMBASE databases for relevant studies up to December 2006.
• Included trials with daily vitamin C doses of at least 0.2g and placebo controls.

Main Results:

• Prophylactic vitamin C showed a non-significant 4% reduction in common cold incidence (RR 0.96).
• A significant reduction in cold duration was observed: 8% for adults and 13.6% for children.
• Vitamin C supplementation did not significantly reduce cold incidence or severity in the general population.
• A subgroup analysis of individuals under severe physical stress (e.g., marathon runners) indicated a 50% reduction in cold incidence.

Conclusions:

• Routine high-dose vitamin C prophylaxis is not recommended for the general population due to lack of significant incidence reduction.
• Vitamin C supplementation may be beneficial for reducing cold duration in both adults and children.
• Individuals exposed to extreme physical exertion or cold environments may benefit from vitamin C supplementation for cold prevention.